Scientists search for clues in blood and tumors to predict who benefits from cancer immunotherapy
NCT ID NCT03514368
Summary
This study aims to find biological markers in the blood and tumors of patients receiving immunotherapy for advanced solid cancers. Researchers will collect samples from about 770 patients to learn why some people respond well to treatment while others experience side effects or see no benefit. The goal is to gather knowledge that could help doctors better predict treatment outcomes in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Rangueil
RECRUITINGToulouse, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital Larrey
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Universitaire Du Cancer de Toulouse - Oncopole
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.